TECHNOLOGY TRANSFER

The Epilogue of NIB research should lead to technology transfer (TT) to companies adopting NIB prototypes (biomedical equipment or medical informatics applications).In this way the clinical needs initially defined with clinical groups are available for use and continuous improvement in the health systems of Uruguay and other countries.

Patents, utility models and trademarks:

DINABANG trademark - applied for DNPI (Act Nº 504494) by the UPI, Central University Research.
DINABANG utility model - pending response from DNPI (Act Nº 4792) by UPI, Central University Research.


Companies collaborating with NIB:

• Apiter


• ARCOS Biomedical - definition of intraocular drug delivery devices.


• Aruya S.A - study and dissemination of TOBII (Sweden) assistive technology in Uruguay.


• Biogénesis - co-operation in manufacturing procedures incorporating a NIB faculty member.


• Biohealth Group Sensor Medica - study and dissemination of biomechanics equipment.


• BullsEye - TT agreement for the commercialisation of CALANEST and REDIENTE.


• CONTROLES S.A - TT agreement for the production and commercialisation of BiliLED.


• e-Medical


• Electroplast S.A


• Humana IT - (Ing. Martín Silva) - TT agreement for the development of SISDIA Renalic.


• Interger Ltd. - (ex CCC del Uruguay) - teaching support to the SABI2020 congress.


• MOVI Technology for Life - TT agreement for the production and commercialisation of DINABANG.


• SAMAY (Ing. Martín Vallarino) - development of assisted ventilation equipment.


• SECA - support to CLABIO2018 event.


• SIAC - (sterilisation equipment).


• Toque y Toque - support to SABI2020 congress.